San Francisco, CA, United States of America

Leon H Parker, Iv

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genentech, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leon H Parker, Iv. Retrieved from https://idiyas.com/inventor/leon-h-parker-iv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leon H Parker, Iv: Innovator in Vascular Development

Introduction

Leon H Parker, Iv is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of vascular development through his innovative research and patents. His work focuses on the modulation of vascular development, which has important implications for medical treatments.

Latest Patents

Leon H Parker, Iv holds a patent titled "Compositions and methods for modulating vascular development." This invention provides methods for using EGFL7 antagonists to modulate vascular development. Additionally, it includes methods for screening modulators of EGFL7 activity and outlines treatment methods using these antagonists. He has 1 patent to his name.

Career Highlights

Leon is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Ellen Filvaroff and Weilan Ye, who have also contributed to advancements in the field of vascular research.

Conclusion

Leon H Parker, Iv is a distinguished inventor whose work in vascular development is paving the way for new medical treatments. His contributions are vital to the ongoing research in this important area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…